title: Impact of adding raltegravir to antiretroviral regimens in patients with blood viral suppression but persistent seminal viral shedding.
authors.affiliation: Department of Clinical and Experimental Medicine, Clinic of Infectious Diseases, University of Foggia, Foggia, Italy.
authors.forename: José R
authors.initials: JR
authors.lastname: Fiore
authors.forename: Fabio
authors.initials: F
authors.lastname: Zoboli
authors.forename: Mariantonietta
authors.initials: M
authors.lastname: Di Stefano
authors.forename: Giuseppina
authors.initials: G
authors.lastname: Faleo
authors.forename: Massimo
authors.initials: M
authors.lastname: Fasano
authors.forename: Teresa A
authors.initials: TA
authors.lastname: Santantonio
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology*; D006801:Humans; D008297:Male; D000068898:Raltegravir Potassium / Q000627:therapeutic use*; D012661:Semen / Q000821:virology*; D016896:Treatment Outcome; D017201:Virus Shedding
chemical_list: D044966:Anti-Retroviral Agents; D000068898:Raltegravir Potassium